RWM
RPRX icon

Raffa Wealth Management’s Royalty Pharma RPRX Stock Holding History

Raffa Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21
Closed -$916 – 1118
2021
Q1 		$916 Hold
21
– – ﹤0.01% 857
2020
Q4 		$1.05K Buy
+21
New +$891 ﹤0.01% 730

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Raffa Wealth Management's RPRX Position: Q2 2021 in Review

Raffa Wealth Management sold out of Royalty Pharma (RPRX) in Q2 2021, closing a stake of 21 shares — an estimated $916 sold.

Raffa Wealth Management first reported a position in RPRX in Q4 2020 and held it in 2 quarters. The position peaked at $1.05K in Q4 2020. 236 funds tracked by Wall St. Rank hold RPRX as of Q2 2021.

  • Raffa Wealth Management reported no remaining Royalty Pharma position as of Q2 2021 after selling out during the quarter.
  • Raffa Wealth Management sold 21 Royalty Pharma shares in Q2 2021, an estimated $916.
  • Raffa Wealth Management first reported a position in Royalty Pharma in Q4 2020 and held it in 2 quarters.
  • Raffa Wealth Management's Royalty Pharma position peaked at $1.05K in Q4 2020.
  • 236 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2021.

Based on Raffa Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2026.